Assignee
NAT JEWISH MED & RES CENTER
US·33 granted patents·20 pending applications·963 citations·filing 1995–2010
Top patents by PatentIndex Score
53 records- 0194US6916799B2Substituted porphyrinsNAT JEWISH MED & RES CENTER·Filed 2001·Granted Jul 12, 2005·51 cites·32 claims
- 0294US6693086B1Systemic immune activation method using nucleic acid-lipid complexesNAT JEWISH MED & RES CENTER·Filed 1998·Granted Feb 17, 2004·274 cites·18 claims
- 0394US6544975B1Substituted porphyrinsNAT JEWISH MED & RES CENTER·Filed 2000·Granted Apr 8, 2003·56 cites·11 claims
- 0493US7999082B2Anti-factor B antibodiesNAT JEWISH MED & RES CENTER·Filed 2005·Granted Aug 16, 2011·33 cites·12 claims
- 0593US6475987B1Tall-1 receptor homologuesNAT JEWISH MED & RES CENTER·Filed 2000·Granted Nov 5, 2002·84 cites·19 claims
- 0691US6110739AMethod to produce novel embryonic cell populationsNAT JEWISH MED & RES CENTER·Filed 1999·Granted Aug 29, 2000·94 cites·15 claims
- 0788US7741300B2Methods of using nucleic acid vector-lipid complexesNAT JEWISH MED & RES CENTER·Filed 2005·Granted Jun 22, 2010·13 cites·9 claims
- 0888US7374934B2Cell populations and methods of production thereofNAT JEWISH MED & RES CENTER·Filed 2002·Granted May 20, 2008·15 cites·5 claims
- 0988US7195766B2Product and process for liquefaction of mucus or sputumNAT JEWISH MED & RES CENTER·Filed 2003·Granted Mar 27, 2007·21 cites·17 claims
- 1083US6264950B1Product and process for T lymphocyte immunosuppressionNAT JEWISH MED & RES CENTER·Filed 1999·Granted Jul 24, 2001·44 cites·34 claims
- 1182US6555318B2Method for identification of cell growth or differentiation factorsNAT JEWISH MED & RES CENTER·Filed 2001·Granted Apr 29, 2003·7 cites·15 claims
- 1276US6579694B2Agar medium for the growth of Mycobacterium tuberculosisNAT JEWISH MED & RES CENTER·Filed 2001·Granted Jun 17, 2003·9 cites·23 claims
- 1375US7498047B2Methods for treatment of thiol-containing compound deficient conditionsNAT JEWISH MED & RES CENTER·Filed 2005·Granted Mar 3, 2009·2 cites·6 claims
- 1473US7282477B2Cystatin C as an antagonist of TGF-β and methods related theretoNAT JEWISH MED & RES CENTER·Filed 2004·Granted Oct 16, 2007·6 cites·12 claims
- 1573US6951733B2Method for testing drug susceptibility of Mycobacterium tuberculosisNAT JEWISH MED & RES CENTER·Filed 2003·Granted Oct 4, 2005·6 cites·19 claims
- 1672US7090865B2Composition and method for treating autoimmune hemolytic anemiaNAT JEWISH MED & RES CENTER·Filed 2002·Granted Aug 15, 2006·4 cites·21 claims
- 1771US5674483ATreatment for diseases involving inflammationNAT JEWISH MED & RES CENTER·Filed 1995·Granted Oct 7, 1997·33 cites·43 claims
- 1871US2010272739A1Modulation of Gamma-Delta T Cells to Regulate Airway HyperresponsivenessNAT JEWISH MED & RES CENTER·Filed 2009·Application pending·0 cites
- 1968US6248723B1Method for treatment of inflammatory diseaseNAT JEWISH MED & RES CENTER·Filed 1998·Granted Jun 19, 2001·21 cites·38 claims
- 2068US5985261AUse of thioredoxin-like molecules for induction of MnSOD to treat oxidative damageNAT JEWISH MED & RES CENTER·Filed 1997·Granted Nov 16, 1999·39 cites·37 claims
- 2165US6060054AProduct for T lymphocyte immunosuppressionNAT JEWISH MED & RES CENTER·Filed 1996·Granted May 9, 2000·29 cites·31 claims
- 2265US5908620ATreatment for diseases involving inflammationNAT JEWISH MED & RES CENTER·Filed 1997·Granted Jun 1, 1999·24 cites·3 claims
- 2364US6737398B1Modulation of γδ T cells to regulate airway hyperresponsivenessNAT JEWISH MED & RES CENTER·Filed 2000·Granted May 18, 2004·5 cites·18 claims
- 2464US6630313B2Phosphatidyl serine receptors and uses thereofNAT JEWISH MED & RES CENTER·Filed 2001·Granted Oct 7, 2003·9 cites·24 claims
- 2559US5976819AProduct and process to regulate actin polymerization in T lymphocytesNAT JEWISH MED & RES CENTER·Filed 1995·Granted Nov 2, 1999·22 cites·22 claims
- 2659US2008207556A1Product and Process for Inhibition of Biofilm DevelopmentNAT JEWISH MED & RES CENTER·Filed 2008·Application pending·0 cites
- 2758US6040152AMethod and assay for regulation of T cell proliferationNAT JEWISH MED & RES CENTER·Filed 1996·Granted Mar 21, 2000·29 cites·12 claims
- 2857US2006074062A1Substituted porphyrinsNAT JEWISH MED & RES CENTER·Filed 2005·Application pending·0 cites
- 2957US2008063629A1Method for production of neutrophils and uses thereforNAT JEWISH MED & RES CENTER·Filed 2007·Application pending·0 cites
- 3055US6132978AMethod to regulate CD40 signalingNAT JEWISH MED & RES CENTER·Filed 1996·Granted Oct 17, 2000·16 cites·9 claims
- 3154US7169570B2Method to identify regulators of cellular activation using Bcl10NAT JEWISH MED & RES CENTER·Filed 2004·Granted Jan 30, 2007·2 cites·47 claims
- 3254US2008070256A1Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses ThereofNAT JEWISH MED & RES CENTER·Filed 2007·Application pending·0 cites
- 3352US2003148445A1TALL-1 nucleic acid molecules, proteins, receptors and methods of use thereofNAT JEWISH MED & RES CENTER·Filed 2002·Application pending·0 cites
- 3450US2007269426A1Use of Soluble Gammadelta Cell Receptors for Regulating T Cell FunctionNAT JEWISH MED & RES CENTER·Filed 2007·Application pending·0 cites
- 3550US2006030539A1Product and process for inhibition of biofilm developmentNAT JEWISH MED & RES CENTER·Filed 2005·Application pending·0 cites
- 3650US2003077284A1Product and method for treatment of conditions associated with receptor-desensitizationNAT JEWISH MED & RES CENTER·Filed 2002·Application pending·0 cites
- 3749US2011002980A1Vaccines using nucleic acid-lipid complexesNAT JEWISH MED & RES CENTER·Filed 2010·Application pending·0 cites
- 3847US7160681B2Method for regulating cell growth and assays related theretoNAT JEWISH MED & RES CENTER·Filed 2002·Granted Jan 9, 2007·1 cites·13 claims
- 3947US2008248025A1Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related ConditionsNAT JEWISH MED & RES CENTER·Filed 2008·Application pending·0 cites
- 4045US2001055753A1Method to regulate CD40 signalingNAT JEWISH MED & RES CENTER·Filed 2001·Application pending·0 cites
- 4145US2003143644A1Product and process to regulate actin polymerization in T lymphocytesNAT JEWISH MED & RES CENTER·Filed 2002·Application pending·0 cites
- 4245US2006111315A1Method for inhibition of pathogenic microorganismsNAT JEWISH MED & RES CENTER·Filed 2005·Application pending·0 cites
- 4344US2003232738A1Method and composition for increasing CD4+ T lymphocyte immune responsivenessNAT JEWISH MED & RES CENTER·Filed 2002·Application pending·0 cites
- 4444US2007179087A1Method for treating inflammatory diseases using heat shock proteinsNAT JEWISH MED & RES CENTER·Filed 2006·Application pending·0 cites
- 4544US2003202962A1Gene therapy for effector cell regulationNAT JEWISH MED & RES CENTER·Filed 2003·Application pending·0 cites
- 4638US2006094054A1Fibulin-3 and uses thereofNAT JEWISH MED & RES CENTER·Filed 2005·Application pending·0 cites
- 4737US5906815ATreatment for diseases involving inflammationNAT JEWISH MED & RES CENTER·Filed 1997·Granted May 25, 1999·4 cites·4 claims
- 4837US2002091073A1Method to limit immunodeficiency virus infection and compounds thereforNAT JEWISH MED & RES CENTER·Filed 2001·Application pending·0 cites
- 4936US2004181037A1Phosphatidyl serine receptors and uses thereofNAT JEWISH MED & RES CENTER·Filed 2003·Application pending·0 cites
- 5034US5976786AScreening methods for the identification of compounds that modulate apoptosis in immunodeficiency virus infected cellsNAT JEWISH MED & RES CENTER·Filed 1996·Granted Nov 2, 1999·8 cites·7 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NAT JEWISH MED & RES CENTER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →